250 related articles for article (PubMed ID: 16477563)
1. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.
Vasan A; Renjifo B; Hertzmark E; Chaplin B; Msamanga G; Essex M; Fawzi W; Hunter D
Clin Infect Dis; 2006 Mar; 42(6):843-52. PubMed ID: 16477563
[TBL] [Abstract][Full Text] [Related]
2. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection.
Kiwanuka N; Laeyendecker O; Robb M; Kigozi G; Arroyo M; McCutchan F; Eller LA; Eller M; Makumbi F; Birx D; Wabwire-Mangen F; Serwadda D; Sewankambo NK; Quinn TC; Wawer M; Gray R
J Infect Dis; 2008 Mar; 197(5):707-13. PubMed ID: 18266607
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.
Baeten JM; Chohan B; Lavreys L; Chohan V; McClelland RS; Certain L; Mandaliya K; Jaoko W; Overbaugh J
J Infect Dis; 2007 Apr; 195(8):1177-80. PubMed ID: 17357054
[TBL] [Abstract][Full Text] [Related]
4. Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and non-recombinant HIV-1 genotypes.
Koulinska IN; Villamor E; Msamanga G; Fawzi W; Blackard J; Renjifo B; Essex M
Virus Res; 2006 Sep; 120(1-2):191-8. PubMed ID: 16621098
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of multivitamin supplements and HIV disease progression and mortality.
Fawzi WW; Msamanga GI; Spiegelman D; Wei R; Kapiga S; Villamor E; Mwakagile D; Mugusi F; Hertzmark E; Essex M; Hunter DJ
N Engl J Med; 2004 Jul; 351(1):23-32. PubMed ID: 15229304
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
7. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.
Kaleebu P; French N; Mahe C; Yirrell D; Watera C; Lyagoba F; Nakiyingi J; Rutebemberwa A; Morgan D; Weber J; Gilks C; Whitworth J
J Infect Dis; 2002 May; 185(9):1244-50. PubMed ID: 12001041
[TBL] [Abstract][Full Text] [Related]
8. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
[TBL] [Abstract][Full Text] [Related]
9. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
[TBL] [Abstract][Full Text] [Related]
10. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study.
Laurent C; Bourgeois A; Faye MA; Mougnutou R; Seydi M; Gueye M; Liégeois F; Kane CT; Butel C; Mbuagbaw J; Zekeng L; Mboup S; Mpoudi-Ngolé E; Peeters M; Delaporte E
J Infect Dis; 2002 Aug; 186(4):486-92. PubMed ID: 12195375
[TBL] [Abstract][Full Text] [Related]
11. Slow progression of HIV-1 infection in a cohort of antiretroviral naïve hotel workers in Dar es Salaam, Tanzania as defined by their CD4 cell slopes.
Bakari M; Urassa W; Mhalu F; Biberfeld G; Pallangyo K; Sandström E
Scand J Infect Dis; 2008; 40(5):407-13. PubMed ID: 17943637
[TBL] [Abstract][Full Text] [Related]
12. Women infected with HIV type 1 Brazilian variant, subtype B (B'-GWGR motif) have slower progression to AIDS, compared with patients infected with subtype B (B-GPGR motif).
de Brito A; Komninakis SC; Novoa P; de Oliveira RM; Fonseca LA; Duarte AJ; Casseb J
Clin Infect Dis; 2006 Dec; 43(11):1476-81. PubMed ID: 17083025
[TBL] [Abstract][Full Text] [Related]
13. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
14. Predictors of incident tuberculosis among HIV-1-infected women in Tanzania.
Venkatesh PA; Bosch RJ; McIntosh K; Mugusi F; Msamanga G; Fawzi WW
Int J Tuberc Lung Dis; 2005 Oct; 9(10):1105-11. PubMed ID: 16229221
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 infection and fertility in Dar es Salaam, Tanzania.
Sedgh G; Larsen U; Spiegelman D; Msamanga G; Fawzi WW
Afr J Reprod Health; 2006 Dec; 10(3):41-52. PubMed ID: 17518130
[TBL] [Abstract][Full Text] [Related]
17. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.
Rowhani-Rahbar A; Hawes SE; Sow PS; Toure P; Feng Q; Dem A; Dembele B; Critchlow CW; N'Doye I; Kiviat NB
J Infect Dis; 2007 Sep; 196(6):887-94. PubMed ID: 17703420
[TBL] [Abstract][Full Text] [Related]
18. In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype.
Geldmacher C; Currier JR; Gerhardt M; Haule A; Maboko L; Birx D; Gray C; Meyerhans A; Cox J; Hoelscher M
AIDS; 2007 Jan; 21(2):135-43. PubMed ID: 17197803
[TBL] [Abstract][Full Text] [Related]
19. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
20. Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes.
Renjifo B; Fawzi W; Mwakagile D; Hunter D; Msamanga G; Spiegelman D; Garland M; Kagoma C; Kim A; Chaplin B; Hertzmark E; Essex M
J Hum Virol; 2001; 4(1):16-25. PubMed ID: 11213929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
